Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CD4+ regulatory T cells (Tregs) are a specialized subpopulation of CD4+ T lymphocytes that play a central role in maintaining immune system balance. Their primary function is to suppress excessive or inappropriate immune responses, thereby preventing autoimmunity and maintaining self-tolerance. They achieve these effects through multiple mechanisms such as cytokine secretion (e.g., IL‑10, TGF‑β), metabolic disruption via IL‑2 consumption, direct cell-cell contact inhibition via CTLA‑4 signaling, and modulation of antigen-presenting cell function. Dysfunction or deficiency in regulatory T cell number or activity can result in autoimmune diseases. Conversely, increased numbers or activity can contribute to cancer progression by suppressing anti-tumor immunity.
Modulation of immune cell activity via cytokine secretion (IL-10, TGF-β), IL-2 consumption, CTLA-4 signaling, and modulation of antigen-presenting cell function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CD4+ regulatory T cell (Treg).